Temazepam Capsule
Product Images NDC 51407-508

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Temazepam (NDC 51407-508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-507-05ol (Temazepam 15 mg)

This is a description of Temazepam Capsules, USP containing 15 mg of Temazepam. The medication is to be dispensed with a Medication Guide to each patient. The dosage information can be found in the accompanying Prescribing Information. It should be stored in a well-closed, light-resistant container with a child-resistant closure at a temperature between 15° - 30°C (59° - 86°F). The medication is distributed by GSMS, Incorporated in Camarillo, CA, USA.*

FDA Label Image

51407-508-05ol (Temazepam 30 mg)

This is a description of a medication containing 30 mg of Temazepam in each capsule. It is recommended to dispense the Medication Guide to each patient and store the capsules in a well-closed, light-resistant container with a child-resistant closure. It further advises not to use if the seal is broken and to keep out of reach of children. The storage conditions include keeping it at 25°C with excursions permitted to 15° - 30°C. This medication is marketed by GSMS, Incorporated.*

FDA Label Image

Civ (Temazepam Civ)

FDA Label Image

Temazepam (Temazepam Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.